Anwaar Saeed

24PUBLICATIONS

195CO-AUTHORS

Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosisPolitical economy and social changeCancer genetics

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (24)

Sort by Publication Date:

|Jun 25, 2026

EMPIRE (NSABP FC-13): a biomarker-driven phase II platform trial evaluating cemiplimab-based immunotherapy in microsatellite-stable colorectal cancer with ctDNA-defined minimal residual disease.

|Mar 30, 2026

Quemliclustat and chemotherapy with or without zimberelimab in metastatic pancreatic adenocarcinoma: a randomized phase 1 trial.

Zev A Wainberg, Gulam A Manji, Nathan Bahary

|Feb 26, 2026

Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer: ASCO Guideline Update.

Manish A Shah, Erin B Kennedy, Dana Deighton

|Feb 05, 2026

Is Seeing Believing? Imaging Accuracy and the Challenge of Clinical Staging in Mismatch Repair-Deficient Colon Cancer.

Anwaar Saeed, Thomas J George

|Jan 10, 2026

Young-Onset Gastric Cancer: Clinical and Genetic Perspectives.

Isabella Michelon, Anwaar Saeed

|Sep 27, 2025

Chemoimmunotherapy in Advanced Biliary Tract Cancers: A Meta-Analysis of Clinical Outcomes.

Alireza Tojjari, Sepideh Razi, Osama M Younis

Pageof 4

Frequent Collaborators

Hassan M Abushukair

Zev Wainberg

Kohei Shitara

Yi-Hsiang Huang

Bernhard Scheiner

Martin Schönlein

Jaekyung Cheon

Yelena Y Janjigian

Lorenz Balcar

Ludimila Cavalcante

Frequent Collaborators

Hassan M Abushukair

Zev Wainberg

Kohei Shitara

Yi-Hsiang Huang